Saturday 17 October 2026
Export ADUS’s income statement to Excel — free account
Addus HomeCare Corporation
ADUS Healthcare Medical Care Facilities
Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024. In the quarter to June 2026, revenue grew 8.01%, EPS grew 24.2%, free cash flow grew 81.7% and total debt fell 63.6%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
116.05
0.44
−0.38%
Follow ADUS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
17.63 | 17.31 | 20.61 | 25.27 |
+8 more quarters Free account |
P/S ratio |
1.24 | 1.18 | 1.36 | 1.58 | |
P/FCF ratio |
11.88 | 12.41 | 18.70 | 22.15 | |
P/Operating CF |
45.93 | 32.54 | 103.33 | 41.59 | |
P/B ratio |
1.60 | 1.53 | 1.79 | 2.03 | |
Price to Tangible BV |
45.15 | 89.72 | 0.00 | 0.00 | |
EV/Sales |
1.22 | 1.17 | 1.39 | 1.62 | |
EV/EBITDA |
10.83 | 10.58 | 12.66 | 15.57 | |
EV/Operating CF |
11.09 | 11.68 | 17.75 | 21.15 | |
EV/FCF |
11.64 | 12.33 | 19.09 | 22.67 | |
Quick Ratio |
1.46 | 1.66 | 1.56 | 1.50 | |
Current Ratio |
1.69 | 1.83 | 1.80 | 1.66 | |
Net Debt/EBITDA |
(0.87) | (0.31) | 0.84 | 1.29 | |
Debt/Assets |
4.23% | 6.36% | 8.42% | 10.59% | |
Debt/Equity |
0.05 | 0.08 | 0.11 | 0.14 | |
Asset Turnover |
1.03 | 1.02 | 1.00 | 1.05 | |
Operating CF/Net income |
1.45 | 2.09 | 0.63 | 2.24 | |
Capex/Depreciation |
(0.30) | (0.39) | (0.59) | (0.41) | |
Interest Coverage |
22.59 | 15.84 | 15.51 | 9.85 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.80% | 21.39% | 20.69% | 21.91% | |
Intangible Assets out of Total Assets |
0.76 | 0.76 | 0.76 | 0.77 | |
Share Based Compensation of Revenue |
1.16% | 1.38% | 1.22% | 1.18% | |
Graham Net Nets |
(0.01) | (0.03) | (0.04) | (0.05) | |
Graham Number |
89.72 | 86.42 | 83.95 | 78.13 | |
Earnings Yield |
5.67% | 5.78% | 4.85% | 3.96% | |
Free Cash Flow Yield |
8.42% | 8.06% | 5.35% | 4.51% | |
Revenue per Share |
20.63 | 19.99 | 20.67 | 20.05 | |
Operating CF per Share |
2.19 | 2.88 | 1.04 | 2.84 | |
Capex per Share |
(0.07) | (0.09) | (0.15) | (0.11) | |
Free Cash Flow per Share |
2.12 | 2.79 | 0.89 | 2.73 | |
Cash per Share |
5.44 | 5.66 | 4.52 | 5.64 | |
Shareholders Equity per Share |
62.77 | 61.35 | 60.12 | 58.10 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
62.77 | 61.35 | 60.12 | 58.10 | |
Free Cash Flow |
38.69 | 50.67 | 16.11 | 49.34 | |
Working Capital |
116.00 | 123.40 | 120.00 | 103.86 | |
Capital Expenditures |
(1.32) | (1.69) | (2.66) | (1.93) | |
Net Current Asset Value |
(24.18) | (46.66) | (82.51) | (112.30) | |
EV/EBIT |
12.15 | 11.91 | 14.28 | 17.70 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | |
Price to Operating Income |
12.40 | 11.98 | 13.99 | 17.30 | |
| Other line items | |||||
Average Receivables |
142.61 | 139.72 | 137.29 | 115.33 | |
Average Payables |
16.86 | 21.00 | 22.00 | 22.20 | |
Average Assets |
1,432.71 | 1,421.64 | 1,424.97 | 1,287.92 | |
Average Common Equity |
1,085.01 | 1,055.77 | 1,027.90 | 998.80 |
Columns are period end dates